This Article Full Text Full Text (PDF) All Versions of this Article: 2/6/533    most recent CIRCOUTCOMES.109.848259v1 Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Bach, D. S. Articles by Gualano, S. K. PubMed PubMed Citation Articles by Bach, D. S. Articles by Gualano, S. K. Related Collections CV surgery: valvular disease Compliance/Adherence Related Article

Original Articles

Evaluation of Patients With Severe Symptomatic Aortic Stenosis Who Do Not Undergo Aortic Valve Replacement

The Potential Role of Subjectively Overestimated Operative Risk

David S. Bach, MD; Derrick Siao, MD; Steven E. Girard, MD, PhD; Claire Duvernoy, MD; Benjamin D. McCallister, Jr, MD and Sarah K. Gualano, MD

From the Department of Internal Medicine, Division of Cardiovascular Medicine (D.S.B., D.S., C.D., S.K.G.), University of Michigan, Ann Arbor; Michigan Heart and Vascular Institute (S.E.G., B.D.M.), Ypsilanti; and the VA Ann Arbor Healthcare System (C.D.), Ann Arbor, Mich.

Correspondence to David S. Bach, MD, CVC Room 2147, SPC 5853, the University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI 48109-5853. E-mail dbach{at}umich.edu

Received January 2, 2009; accepted August 28, 2009.

Background— Some patients with severe symptomatic aortic stenosis (AS) do not undergo aortic valve replacement (AVR) despite demonstrated symptomatic and survival advantages and despite unequivocal guideline recommendations for surgical evaluation.

Methods and Results— In 3 large tertiary care institutions (university, Veterans Affairs, and private practice) in Washtenaw County, Mich, patients were identified with unrefuted echocardiography/Doppler evidence of severe AS during calendar year 2005. Medical records were retrospectively reviewed for symptoms, referral for AVR, calculated operative risk for AVR, and rationale as to why patients did not undergo valve replacement. Of 369 patients with severe AS, 191 (52%) did not undergo AVR. Of these, 126 (66%, 34% of total) had symptoms consistent with AS. The most common reasons cited for absent intervention were comorbidities with high operative risk (61 patients [48%]), patent refusal (24 patients [19%]), and symptoms unrelated to AS (24 patients [19%]). Operated patients had a lower Society of Thoracic Surgery–calculated perioperative mortality risk than unoperated patients (1.8% [interquartile range, 1.0 to 3.0%] versus 2.7% [interquartile range, 1.6 to 5.5%], P<0.001). However, 28 (24%) of 126 unoperated symptomatic patients had a calculated perioperative risk less than the median risk for patients who underwent AVR. Only 57 (30%) of 191 unoperated patients were evaluated by a cardiac surgeon. There were similar rates of intervention across practice settings, and similar rates of unoperated patients despite symptoms and low operative risk.

Conclusions— One third of patients with severe AS are symptomatic but do not undergo AVR, with similar findings in multiple practice environments. For most unoperated patients, objectively calculated operative risks did not appear prohibitive. Despite this, a minority of unoperated patients were referred for surgical consultation. Some patients with severe symptomatic AS may be inappropriately denied access to potentially life-saving therapy.

Key Words: aortic valve stenosis • heart valves • standards

Related Article

Sharing Decision Making About Cardiac Surgery: Improving the Quality of the Decision to Undergo or Forego Surgery

Victor M. Montori and Henry H. Ting
Circ Cardiovasc Qual Outcomes 2009 2: 519-521. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				V. M. Montori and H. H. Ting Sharing Decision Making About Cardiac Surgery: Improving the Quality of the Decision to Undergo or Forego Surgery Circ Cardiovasc Qual Outcomes, November 1, 2009; 2(6): 519 - 521. [Full Text] [PDF]